Drugs / PfSPZ (NF54)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02780154 | Aug → Dec 2016 | Plasmodium falciparum malaria | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PfSPZ (NF54) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02780154 ↗ |
| Modality | Vaccine | “PfSPZ (NF54) is a candidate vaccine” NCT02780154 ↗ |
| Route | Intravenous | “administered by direct venous inoculation (DVI)” NCT02780154 ↗ |